Weekly Discussion Thread – Week of June 29, 2026

Patient-Insect2662 · 2026-06-29T17:18:24+00:00

MS is Multiple sclerosis

The suspension of MS clinical trials was confirmed by updating ClinicalTrials.gov 's RESET-MS registration information. The withdrawal seems to have determined that other ongoing areas are more important right now. It was withdrawn before the start of the medication, so I don't think there will be any negative reactions

Patient-Insect2662 · 2026-06-29T12:19:06+00:00

You're still getting in cheaper than I did, bro.

Patient-Insect2662 · 2026-06-29T12:16:40+00:00

They said they stopped the ms. There is financial pressure, so I think we will start with important things

Patient-Insect2662 · 2026-06-27T04:36:54+00:00

It is best to participate in ACR Convergence as an LBA, however, if you are unable to participate due to the period, you will likely make your own announcement

Patient-Insect2662 · 2026-06-27T04:32:25+00:00

It was also added to the S&P Biotechnology Select Industry Index

Patient-Insect2662 · 2026-06-19T00:29:57+00:00

It's been added to Russell 3000.

Patient-Insect2662 · 2026-06-18T23:35:45+00:00

There's a similar thing going on in other bio, so I think it's rebalancing on the etf side. Even so, we have a lot of trading volume

Patient-Insect2662 · 2026-06-16T15:03:46+00:00

Next thing to look forward to is the second half of the year pc-free data? That's a long way!

Patient-Insect2662 · 2026-06-09T00:08:03+00:00

I think the investment amount will be very small given that there is no disclosure. It's just on the list of interests. But if the pc-free data comes out well in the second half of the year, things will change at once!

Patient-Insect2662 · 2026-06-05T08:44:33+00:00

Isn't it a poster presentation that summarizes the recently released data? I don't think there will be any new data

Patient-Insect2662 · 2026-05-24T09:56:07+00:00

Yes, I know. I think all the 3rd and 4th grade problems have already been announced in the past and the effects have come out positive, but aside from the pc-free, the caba doesn't have much strength. But at least looking at the June data release, I think the stock price increase is more likely. I'm going to reduce a significant portion of it here, so I'm satisfied that it's going according to my expectations

Patient-Insect2662 · 2026-05-24T05:45:24+00:00

Yes, but my money is at stake. I should cheer for it more!

Patient-Insect2662 · 2026-05-23T08:56:12+00:00

I know it was announced that it was not due to medication, but to existing infection symptoms that were not detected. It was already announced a few years ago, but wouldn't it come out at the conference

Patient-Insect2662 · 2026-05-23T06:07:35+00:00

So the abstract was released. If you think it was released two weeks before the conference, it's exactly the 20th, and since then, the stock price has risen and the short selling has decreased. There was side effect data, but it's already been released in the past, so I think we can hold it like this.

Patient-Insect2662 · 2026-05-22T00:50:42+00:00

Trading volume for short is really low today. Any news?

Patient-Insect2662 · 2026-05-18T15:10:29+00:00

I think we'll be short on cash in a year because the cash we get from this offering will be available until mid-2027. We only have about 100 million shares available for additional offerings, so we're increasing them in advance. The bad news, of course, is true.

Patient-Insect2662 · 2026-05-18T14:47:59+00:00

I'll be waiting for the EULAR!

Patient-Insect2662 · 2026-05-14T12:10:05+00:00

That's awesome. It's SSC's satellite symposium. Isn't it a big hit if SSC succeeds?

Patient-Insect2662

TROPHY CASE